Reassessment of reimbursement status of the remaining subgroups of ATC group C

18 December 2006

The Danish Medicines Agency previously notified companies and a number of scientific societies and patient organisations about which ATC groups and subgroups would be the first to be reassessed, cf. the fact box to the right. During autumn, we expect to start reassessing reimbursement status of the remaining subgroups of ATC group C:

  • C01: Medicinal products for cardiac therapy
  • C02: Antihypertensives
  • C04: Peripheral vasodilators
  • C05: Vasoprotectives

For further information, please contact the Reimbursement Department, medicintilskud@dkma.dk.

The Danish Medicines Agency, 4 July 2006

 

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.